Total Payments
$879.34
2024 Payments
$97.24
Companies
23
Transactions
52
Medicare Patients
3,482
Medicare Billing
$154,074
Payment Breakdown by Category
Food & Beverage$879.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $879.34 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $251.14 | 16 | $0 (2019) |
| ABBVIE INC. | $176.92 | 9 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $40.24 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.72 | 2 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.49 | 2 | $0 (2020) |
| Organogenesis Inc. | $30.88 | 1 | $0 (2024) |
| Kaleo, Inc. | $30.35 | 2 | $0 (2019) |
| Amgen Inc. | $29.87 | 2 | $0 (2022) |
| Abbott Laboratories | $26.27 | 2 | $0 (2022) |
| Sanofi Pasteur Inc. | $21.51 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97.24 | 5 | Organogenesis Inc. ($30.88) |
| 2023 | $134.28 | 7 | AbbVie Inc. ($88.01) |
| 2022 | $122.93 | 7 | ABBVIE INC. ($59.84) |
| 2021 | $33.55 | 2 | Amarin Pharma Inc. ($17.53) |
| 2020 | $80.63 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($31.72) |
| 2019 | $85.73 | 6 | Shire North American Group Inc ($55.60) |
| 2018 | $173.11 | 11 | Shire North American Group Inc ($110.66) |
| 2017 | $151.87 | 9 | Shire North American Group Inc ($84.88) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: WOUND CARE | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 03/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: VACCINES | ||||||
| 11/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/19/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 06/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Oncology | ||||||
| 03/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Obesity | ||||||
| 10/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: WOMENS HEALTH | ||||||
| 08/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes Care | ||||||
| 07/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/09/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Inflammation | ||||||
| 02/02/2022 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Neuroscience | ||||||
| 06/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular | ||||||
| 03/09/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ANALGESIC | ||||||
| 12/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 08/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.17 | General |
| 03/10/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 745 | 972 | $76,092 | $34,733 |
| 2022 | 16 | 740 | 979 | $76,922 | $33,883 |
| 2021 | 17 | 794 | 1,100 | $82,643 | $36,846 |
| 2020 | 22 | 1,203 | 1,618 | $118,532 | $48,612 |
Total Patients
3,482
Total Services
4,669
Medicare Billing
$154,074
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 141 | $29,862 | $11,118 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $12,224 | $7,844 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 121 | $18,136 | $7,275 | 40.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,511 | $1,791 | 71.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 77 | 98 | $2,744 | $1,286 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 94 | 127 | $1,860 | $1,067 | 57.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 79 | 99 | $2,195 | $1,025 | 46.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 64 | 85 | $1,785 | $809.20 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $494.00 | $484.12 | 98.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 23 | 23 | $897.00 | $435.16 | 48.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 20 | $702.00 | $329.20 | 46.9% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 15 | 19 | $684.00 | $315.40 | 46.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 16 | 17 | $663.00 | $306.34 | 46.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 30 | 40 | $520.00 | $226.40 | 43.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 28 | 36 | $324.00 | $182.88 | 56.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 13 | 17 | $323.00 | $150.28 | 46.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 11 | 14 | $168.00 | $88.76 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 140 | $29,245 | $10,341 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $14,614 | $9,514 | 65.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 135 | $19,974 | $7,838 | 39.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 76 | 95 | $2,660 | $1,256 | 47.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 75 | 94 | $2,162 | $979.38 | 45.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $1,034 | $753.94 | 72.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 45 | 69 | $1,449 | $661.72 | 45.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 121 | 184 | $1,840 | $545.58 | 29.7% |
About Dr. Richard Sharp, M.D
Dr. Richard Sharp, M.D is a Family Medicine healthcare provider based in Lehi, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508817453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Sharp, M.D has received a total of $879.34 in payments from pharmaceutical and medical device companies, with $97.24 received in 2024. These payments were reported across 52 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($879.34).
As a Medicare-enrolled provider, Sharp has provided services to 3,482 Medicare beneficiaries, totaling 4,669 services with total Medicare billing of $154,074. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lehi, UT
- Active Since 05/15/2006
- Last Updated 11/27/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508817453
Products in Payments
- VYVANSE (Drug) $185.17
- VRAYLAR (Drug) $161.18
- MYDAYIS (Drug) $97.69
- CONTRAVE (Drug) $32.74
- AFFINITY (Medical Supply) $30.88
- ADDYI (Drug) $24.94
- PENTACEL (Drug) $21.51
- PREVNAR 20 (Biological) $19.09
- Otezla (Drug) $18.40
- WaveWriter Alpha Prime 16 (Device) $18.20
- Vascepa (Drug) $17.53
- Evzio (Drug) $17.50
- JARDIANCE (Drug) $17.42
- Horizant (Drug) $17.28
- SEGLENTIS (Drug) $16.79
- STIOLTO RESPIMAT (Drug) $16.32
- NAPRELAN (Drug) $16.02
- LILETTA (Drug) $15.74
- XIFAXAN (Drug) $15.30
- FREESTYLE LIBRE 2 (Device) $15.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lehi
Toran Macarthur, M.d, M.D
Family Medicine — Payments: $12,446
Family Medicine $12,446
Dr. Tauaina Ngatuvai, M.d, M.D
Family Medicine — Payments: $12,080
Family Medicine $12,080
Cheryl Johnson, M.d, M.D
Family Medicine — Payments: $11,288
Family Medicine $11,288
Shawn Mcmanus, Do, DO
Family Medicine — Payments: $6,001
Family Medicine $6,001
David Kimball, D.o., D.c, D.O., D.C
Family Medicine — Payments: $2,841
Family Medicine $2,841
Dianne Farley Jones, Md, MD
Family Medicine — Payments: $769.67
Family Medicine $769.67